Predicting blood clots in cancer patients at risk
Part of Blood & lymphatic, Cancer clinical trials.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of cancer that is more likely to cause blood clots (lung, pancreatic, stomach, or glioblastoma).
- You have not yet started any treatment for your cancer (like chemotherapy or immunotherapy).
- You have not had a blood clot (such as a DVT or PE) in the past year.
- You are not taking blood-thinning medications (like Lovenox, heparin, or warfarin) and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
This study looks at how blood clotting problems affect people with cancer. It tests whether certain cancers or severe infections cause changes in the body's ability to break down blood clots.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
Hear when a new Solid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.